Biotech proved a surprisingly bright spot in 2022’s startup correction

1 Mobility Needs

Biotech proved a surprisingly bright spot in 2022’s startup correction

While not totally immune to 2022’s market correction, biotech fundraising proved to be more resilient than other sectors.

Biotech proved a surprisingly bright spot in 2022’s startup correction by Rebecca Szkutak originally published on TechCrunch

Biotech proved a surprisingly bright spot in 2022’s startup correction

2023-02-26 05:00

13 views

Same Tag Posts

  1. MagicSchool thinks AI in the classroom is inevitable, so it’s aiming to help teachers and students use it properly ()
  2. Zuckerberg disses closed-source AI competitors as trying to ‘create God’ ()
  3. Andrew Ng plans to raise $120M for next AI Fund ()
  4. VW taps Rivian in $5B EV deal and the fight over Fisker’s assets ()
  5. FCC rule would make carriers unlock all phones after 60 days ()
  6. Dream Chaser spaceplane is off the manifest for ULA’s second Vulcan launch ()
  7. Google improves search experience in the Chrome mobile app ()
  8. Persona’s founders are certain the world can use another humanoid robot ()
  9. This Week in AI: The fate of generative AI is in the courts’ hands ()
  10. TikTok’s Instagram rival, Whee, has no traction ()

Same Category Posts